Evolution of Clinical Evidence of the Blood-based Nodify Lung Nodule Risk Assessment: Continued Evaluation through Real World Use and the ALTITUDE Randomized Control Trial
WEBINAR REPLAY: Join Dr. Susan Garwood from HCA Healthcare and Dr. Gerard Silvestri from the Medical University of South Carolina as they discuss the latest developments, research, and real world applications of Nodify Lung® testing.
Keywords: lung nodule, lung cancer, biomarkers, lung cancer test
Learn more: nodify.com
- WEBINAR REPLAY: Evolution of Clinical Evidence of the Blood-based Nodify Lung Nodule Risk Assessment ( Download)
- Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study ( Download)
- How does Nodify Lung™ testing work ( Download)
- Enhanced Performance of the Nodify XL2 Blood-Based Lung Nodule Test ( Download)
- Webinar Replay: Standardizing Use of Diagnostic Tests in Lung Cancer ( Download)
- Optimizing Diagnosis of Malignant Lung Nodules with the Use of Biomarker Testing and Robotic Bronch ( Download)
- The Importance of Nodify ( Download)
- Evaluating lung nodules during the COVID-19 pandemic using blood-based biomarkers ( Download)
- WEBINAR REPLAY: Cancer Can't Wait: Nodule Evaluation and Early Lung Cancer Diagnosis During COVID-19 ( Download)
- What does the Nodify XL2 test measure ( Download)
- What does the Nodify CDT test measure ( Download)
- Nodify Lung Collection Video – 2021 ( Download)
- Building a Nodule Program & the Role of Biodesix Testing ( Download)
- Ask the Experts: Using Blood-Based Testing to Direct Care in Lung Cancer ( Download)
- Incidental pulmonary nodule (IPN): A pandora's box. ( Download)
